Get the Stockscreener App
1.03
4.16%
0.0411
Lava Therapeutics Nv Stock (LVTX) Forecast
The Lava Therapeutics Nv (LVTX) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $2.9504, representing a +186.45% increase from the current price of $1.03. The highest analyst price target is $2.8507, and the lowest is $3.0501.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month LVTX Price Target
Average 4.2271
(+310.39% Upside)
Is Lava Therapeutics Nv (LVTX) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 32.45 | Neutral |
| STOCH(9,6) | 4.0572 | Buy |
| STOCHRSI(14) | 8.1037 | Buy |
| MACD(12,26) | -0.1859 | Sell |
| ADX(14) | 26.58 | Sell |
| William %R | -93.42 | Buy |
| CCI(14) | -81.13 | Neutral |
Buy: 3
Sell: 2
Neutral: 2
Summary: Buy
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
1.1974
Sell
|
1.1742
Sell
|
| MA20 |
1.4297
Sell
|
1.34
Sell
|
| MA50 |
1.6261
Sell
|
1.54
Sell
|
| MA100 |
1.6812
Sell
|
1.6957
Sell
|
| MA200 |
2.1243
Sell
|
1.7867
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, LVTX could be considered a Strong Sell, with 17 technical analysis indicators signaling 3 Buy signals, 12 signaling Sell signals and 2 Neutral signals. This might not be a good time to consider opening new positions on LVTX, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 32.45 indicates that LVTX is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 4.0572 indicates that LVTX is oversold. This indicates that LVTX price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 8.1037 indicates that LVTX is oversold. This suggests that LVTX price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 26.58 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -81.13 indicates that LVTX is still oversold but not to an extreme extent.
Long-term LVTX price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Lava Therapeutics Nv financial reports and earnings history, Lava Therapeutics Nv (LVTX) stock could reach $10.06 by 2030, $37.72 by 2040 and $73.15 by 2050. See the projected annual prices until 2050 of the Lava Therapeutics Nv stock below:
- Lava Therapeutics Nv (LVTX) is expected to reach an average price of $35.92 in 2035, with a high prediction of $35.32 and a low estimate of $33.67. This indicates an $3,387% rise from the last recorded price of $1.03.
- Lava Therapeutics Nv (LVTX) stock is projected to chart a bullish course in 2040, with an average price target of $37.32, representing an $3,524% surge from its current level. The forecast ranges from a conservative $37.42 to a sky-high $37.72.
- Our analysts predict Lava Therapeutics Nv (LVTX) to jump 2,044% by 2045, soaring from $22.22 to an average price of $22.08, potentially reaching $23.23. While $22.22 is the low estimate, the potential upside is significant.
- Lava Therapeutics Nv (LVTX) stock is expected to climb by 2050, reaching an average of $72.81, a $6,969% jump from its current level. However, a wide range of estimates exists, with high and low targets of $73.15 and $72.92, respectively, highlighting the market's uncertainty.
Lava Therapeutics Nv Stock (LVTX) Year by Year Forecast
Lava Therapeutics Nv Stock (LVTX) Price Forecast for 2025
Lava Therapeutics Nv Stock (LVTX) is expected to reach an average price of $4.2271 in 2025, with a high prediction of $5.404 and a low estimate of $3.0501. This indicates an +310.39% rise from the last recorded price of $1.03.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $3.4607 | $3.0501 | $2.8507 | +235.99% |
| February, 2025 | $4.7882 | $3.3696 | $3.6182 | +364.87% |
| March, 2025 | $4.7856 | $4.5178 | $4.475 | +364.62% |
| April, 2025 | $3.8899 | $3.9199 | $4.3497 | +277.66% |
| May, 2025 | $4.9174 | $4.7705 | $4.5386 | +377.41% |
| June, 2025 | $4.6848 | $4.5328 | $4.4842 | +354.84% |
| July, 2025 | $4.7491 | $4.6317 | $4.6854 | +361.08% |
| August, 2025 | $5.7566 | $4.996 | $5.0966 | +458.89% |
| September, 2025 | $6.114 | $5.5003 | $5.404 | +493.59% |
| October, 2025 | $5.4683 | $5.0796 | $5.2083 | +430.90% |
| November, 2025 | $5.2957 | $5.4057 | $5.2189 | +414.15% |
| December, 2025 | $5.1501 | $5.3101 | $5.2107 | +400.00% |
Lava Therapeutics Nv Stock (LVTX) Price Forecast for 2026
The predicted value for Lava Therapeutics Nv (LVTX) in 2026 is set at an average of $3.1184. Estimates vary from a peak of $5.0838 to a trough of $1.153, indicating an +202.75% surge from the present price of $1.03.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $3.8475 | $3.1206 | $5.0838 | +273.54% |
| February, 2026 | $2.8949 | $2.9949 | $3.4044 | +181.06% |
| March, 2026 | $1.2624 | $1.8524 | $2.1187 | +22.56% |
| April, 2026 | $3.3467 | $1.153 | $2.7468 | +224.92% |
| May, 2026 | $3.0741 | $3.0173 | $2.7704 | +198.46% |
| June, 2026 | $2.8116 | $2.8116 | $2.871 | +172.97% |
| July, 2026 | $4.0659 | $3.929 | $3.9022 | +294.75% |
| August, 2026 | $4.4133 | $4.3365 | $4.2296 | +328.48% |
| September, 2026 | $3.7576 | $3.9676 | $4.0208 | +264.82% |
| October, 2026 | $2.7651 | $3.535 | $3.5945 | +168.45% |
| November, 2026 | $3.1225 | $3.1625 | $3.0157 | +203.16% |
| December, 2026 | $3.0068 | $3.0767 | $3.0494 | +191.92% |
Lava Therapeutics Nv Stock (LVTX) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Lava Therapeutics Nv (LVTX) is $5.7187, with a high forecast of $11.41 and a low forecast of $0.0287. This indicates an +455.21% increase from the last price of $1.03.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $3.0243 | $3.0137 | $2.9305 | +193.62% |
| February, 2027 | $2.753 | $2.8117 | $2.738 | +167.28% |
| March, 2027 | $2.846 | $2.856 | $2.8054 | +176.31% |
| April, 2027 | $2.5835 | $2.8235 | $2.7847 | +150.82% |
| May, 2027 | $2.2709 | $2.2909 | $2.3803 | +120.48% |
| June, 2027 | $1.7052 | $1.9352 | $2.1473 | +65.55% |
| July, 2027 | $1.6227 | $1.7127 | $1.7389 | +57.54% |
| August, 2027 | $1.0101 | $1.1951 | $1.4895 | -1.93% |
| September, 2027 | $0.8356 | $0.0344 | $3.443 | -18.87% |
| October, 2027 | $0.1081 | $0.0372 | $1.4487 | -89.50% |
| November, 2027 | $9.25 | $0.0287 | $7.24 | +798.06% |
| December, 2027 | $12.01 | $9.5512 | $11.41 | +1,066% |
Lava Therapeutics Nv Stock (LVTX) Price Forecast for 2028
In 2028, Lava Therapeutics Nv (LVTX) is projected to reach an average price of $14.10, with a high projection of $16.38 and a low estimate of $11.83. This indicates an +1,269% rise from the last price of $1.03.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $12.13 | $11.83 | $11.40 | +1,078% |
| February, 2028 | $11.99 | $12.06 | $12.03 | +1,064% |
| March, 2028 | $14.63 | $12.00 | $12.45 | +1,320% |
| April, 2028 | $16.20 | $16.57 | $16.38 | +1,473% |
| May, 2028 | $15.46 | $15.38 | $15.15 | +1,401% |
| June, 2028 | $13.85 | $15.21 | $15.15 | +1,244% |
| July, 2028 | $13.36 | $13.41 | $13.56 | +1,197% |
| August, 2028 | $13.25 | $13.46 | $13.18 | +1,186% |
| September, 2028 | $14.26 | $14.08 | $14.41 | +1,285% |
| October, 2028 | $13.68 | $14.35 | $14.07 | +1,228% |
| November, 2028 | $14.25 | $13.43 | $13.94 | +1,283% |
| December, 2028 | $13.48 | $14.12 | $13.80 | +1,209% |
Lava Therapeutics Nv Stock (LVTX) Price Forecast for 2029
The 2029 price forecast for Lava Therapeutics Nv Stock (LVTX) is $10.98 on average, with a high prediction of $13.95 and a low estimate of $8.0059. This represents an +965.67% increase from the previous price of $1.03.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $13.62 | $13.66 | $13.61 | +1,222% |
| February, 2029 | $13.46 | $13.75 | $13.40 | +1,207% |
| March, 2029 | $13.91 | $13.96 | $13.95 | +1,251% |
| April, 2029 | $13.63 | $13.88 | $13.80 | +1,223% |
| May, 2029 | $13.44 | $13.31 | $13.34 | +1,205% |
| June, 2029 | $13.11 | $13.16 | $13.19 | +1,173% |
| July, 2029 | $12.77 | $12.87 | $12.92 | +1,140% |
| August, 2029 | $10.72 | $10.61 | $12.63 | +941.01% |
| September, 2029 | $9.2873 | $9.6672 | $9.9999 | +801.68% |
| October, 2029 | $7.0759 | $8.0059 | $8.581 | +586.98% |
| November, 2029 | $9.5208 | $9.7808 | $9.4935 | +824.35% |
| December, 2029 | $9.2157 | $9.4357 | $9.352 | +794.73% |
Lava Therapeutics Nv Stock (LVTX) Price Forecast for 2030
Lava Therapeutics Nv Stock (LVTX) is expected to reach an average price of $8.0265 in 2030, with a high forecast of $10.18 and a low forecast of $5.8739. This signifies an +679.28% surge from the last price of $1.03.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $10.08 | $9.1332 | $10.06 | +879.06% |
| February, 2030 | $10.31 | $10.04 | $10.18 | +900.89% |
| March, 2030 | $9.8441 | $9.8741 | $10.07 | +855.74% |
| April, 2030 | $9.269 | $9.299 | $9.6878 | +799.90% |
| May, 2030 | $8.4576 | $8.6076 | $9.0127 | +721.13% |
| June, 2030 | $8.1125 | $8.2425 | $8.2213 | +687.62% |
| July, 2030 | $7.9211 | $7.8474 | $7.9199 | +669.04% |
| August, 2030 | $7.356 | $7.406 | $7.6248 | +614.17% |
| September, 2030 | $7.2409 | $7.2409 | $7.2297 | +603.00% |
| October, 2030 | $6.9895 | $7.0485 | $7.0946 | +578.59% |
| November, 2030 | $6.2244 | $6.3744 | $6.7882 | +504.31% |
| December, 2030 | $5.7793 | $5.8739 | $6.0981 | +461.09% |
2.88%
2.65%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):